Insider Selling: Snowflake (NYSE:SNOW) Director Sells $110,331,094.68 in Stock

Snowflake Inc. (NYSE:SNOW) Director Frank Slootman sold 437,076 shares of the stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $252.43, for a total value of $110,331,094.68. Following the sale, the director owned 38,046 shares of the company’s stock, valued at approximately $9,603,951.78. The trade was a 91.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Frank Slootman also recently made the following trade(s):

• On Monday, June 1st, Frank Slootman sold 162,924 shares of Snowflake stock. The stock was sold at an average price of $263.70, for a total transaction of $42,963,058.80.
• On Thursday, May 28th, Frank Slootman sold 400,000 shares of Snowflake stock. The shares were sold at an average price of $233.42, for a total transaction of $93,368,000.00.
• On Tuesday, May 26th, Frank Slootman sold 55,350 shares of Snowflake stock. The stock was sold at an average price of $176.52, for a total value of $9,770,382.00.
• On Tuesday, May 19th, Frank Slootman sold 144,650 shares of Snowflake stock. The shares were sold at an average price of $175.45, for a total value of $25,378,842.50.
• On Wednesday, March 18th, Frank Slootman sold 88,701 shares of Snowflake stock. The stock was sold at an average price of $175.93, for a total value of $15,605,166.93.
• On Thursday, March 19th, Frank Slootman sold 11,299 shares of Snowflake stock. The stock was sold at an average price of $175.25, for a total value of $1,980,149.75.
• On Tuesday, March 17th, Frank Slootman sold 7,874 shares of Snowflake stock. The shares were sold at an average price of $175.34, for a total value of $1,380,627.16.
• On Tuesday, March 10th, Frank Slootman sold 2,042 shares of Snowflake stock. The stock was sold at an average price of $182.44, for a total value of $372,542.48.

Snowflake Trading Down 7.4%

Shares of Snowflake stock opened at $241.88 on Thursday. Snowflake Inc. has a 52-week low of $118.30 and a 52-week high of $284.99. The firm has a market capitalization of $83.62 billion, a PE ratio of -68.72 and a beta of 1.35. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 1.30. The company’s fifty day moving average price is $162.02 and its two-hundred day moving average price is $190.30.

Snowflake (NYSE:SNOW) last issued its earnings results on Wednesday, May 27th. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.07. The business had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.32 billion. Snowflake had a negative net margin of 23.79% and a negative return on equity of 50.50%. The firm’s revenue was up 33.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.24 EPS. On average, analysts expect that Snowflake Inc. will post -2.15 EPS for the current year.

Key Headlines Impacting Snowflake

Here are the key news stories impacting Snowflake this week:

• Positive Sentiment: Snowflake used its Summit 26 event to showcase major AI product launches and governance upgrades, including Horizon Context, CoWork enhancements, and Datastream, reinforcing its position as a platform for production-grade enterprise AI. Snowflake Summit 26 Puts Governed Enterprise AI At Center Stage
• Positive Sentiment: Snowflake announced deeper partnerships and ecosystem integrations with Anthropic, Cognizant, Collibra, Ataccama, RelationalAI, ThoughtSpot, and others, suggesting growing enterprise adoption of its AI data cloud. Snowflake and Anthropic Accelerate Enterprise AI Adoption Driven by Rising Demand for Governed AI
• Positive Sentiment: Multiple analysts raised targets or reiterated bullish ratings, including UBS, Piper Sandler, Needham, BTIG, TD Cowen, and Scotiabank, which can support the stock by signaling stronger long-term revenue and earnings expectations.
• Positive Sentiment: Customer and partner announcements from companies like Sanofi, Thomson Reuters, TransUnion, NIQ, and Blue Yonder highlight real-world use cases for Snowflake’s AI and governance tools, strengthening the investment case around monetization. Sanofi Chooses Snowflake to Accelerate its AI-Powered Drug Development
• Neutral Sentiment: Several partner award and marketplace launch announcements at Summit 26 add to the narrative of expanding ecosystem momentum, but they are less likely than product launches or analyst upgrades to move the stock on their own.
• Negative Sentiment: Insider selling by directors Frank Slootman and Mark Garrett may create a modest overhang, even though the sales were disclosed and at least one was tied to a pre-arranged trading plan.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Evercore set a $200.00 price target on Snowflake in a research note on Tuesday, April 14th. Cantor Fitzgerald lifted their price objective on Snowflake from $225.00 to $282.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Scotiabank restated an “outperform” rating on shares of Snowflake in a research note on Thursday, May 28th. Piper Sandler upped their target price on shares of Snowflake from $295.00 to $320.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Wedbush increased their target price on shares of Snowflake from $270.00 to $280.00 and gave the stock an “outperform” rating in a research report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, thirty-five have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $289.90.

Institutional Trading of Snowflake

Large investors have recently made changes to their positions in the business. Kemnay Advisory Services Inc. acquired a new position in Snowflake in the fourth quarter valued at approximately $28,000. Greenline Wealth Management LLC acquired a new stake in Snowflake during the 4th quarter worth $29,000. GoalVest Advisory LLC grew its holdings in Snowflake by 221.4% during the 4th quarter. GoalVest Advisory LLC now owns 135 shares of the company’s stock worth $30,000 after acquiring an additional 93 shares during the period. Physician Wealth Advisors Inc. raised its position in shares of Snowflake by 56.0% during the 4th quarter. Physician Wealth Advisors Inc. now owns 142 shares of the company’s stock valued at $31,000 after acquiring an additional 51 shares during the last quarter. Finally, Emerald Advisers LLC raised its position in shares of Snowflake by 95.2% during the 1st quarter. Emerald Advisers LLC now owns 205 shares of the company’s stock valued at $31,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 65.10% of the company’s stock.

About Snowflake

Snowflake Inc is a cloud-native data platform company that provides a suite of services for storing, processing and analyzing large volumes of data. Its core offering, often described as the Snowflake Data Cloud, combines data warehousing, data lake and data sharing capabilities in a single managed service delivered across major public cloud providers. The platform is designed to support analytics, data engineering, data science and application workloads with a focus on scalability, concurrency and simplified administration.

Key products and capabilities include a multi-cluster, shared-data architecture that separates compute from storage; continuous data ingestion and streaming; support for structured and semi-structured data formats; tools for data governance, security and compliance; and developer frameworks for building data applications.